1-Cyclopropyl-6-fluoro-4-oxo-7-(3-oxopiperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

Catalog No. :
ACBUKN927
CAS No. :
103237-52-1
Molecular Formula :
C17H16FN3O4
Molecular Weight :
345.33

IUPAC Name:1-cyclopropyl-6-fluoro-4-oxo-7-(3-oxopiperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

1-Cyclopropyl-6-fluoro-4-oxo-7-(3-oxopiperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg96%$153.00Login to see priceInquiryInquiry
10mg96%$268.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Cyclopropyl-6-fluoro-4-oxo-7-(3-oxopiperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
IUPAC Name1-cyclopropyl-6-fluoro-4-oxo-7-(3-oxopiperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
Molecular FormulaC17H16FN3O4
Molecular Weight345.33
SMILESO=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CC(NCC4)=O)=C3)C1=O)O
InChI KeyMYYZZOHRULFPOQ-UHFFFAOYSA-N
Synonym3'-Oxociprofloxacin;3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(3-oxo-1-piperazinyl)-;4-Oxociprofloxacin;BAY-q 3542;1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(3-oxo-1-piperazinyl)-3-quinolinecarboxylic Acid;Ciprofloxacin Impurity 13;Ciprofloxacin Lactam;OXOCIPROFLOXACIN USP/EP/BP
CAS No.103237-52-1

Synthetic Route by SureRoute

1. ACBUKN927 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOVKI059 route compound structure diagram
    ACOVKI05993107-30-3 In Stock
  2. Plus
  3. ACCXNG132 route compound structure diagram
    ACCXNG1325625-67-2 In Stock
  4. Then
  5. ACBUKN927 route product structure diagram
    ACBUKN927103237-52-1
Inquiry

2. ACBUKN927 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBUKN927 route product structure diagram
    ACBUKN927103237-52-1
Inquiry

Comments (0)